Abstract:Severe peripheral nerve injury (PNI) often leads to significant movement disorders and intractable pain. Therefore, promoting nerve regeneration while avoiding neuropathic pain is crucial for the clinical treatment of PNI patients. However, established animal models for peripheral neuropathy fail to accurately recapitulate the clinical features of PNI. Additionally, researchers usually investigate neuropathic pain and axonal regeneration separately, leaving the intrinsic relationship between the development of neuropathic pain and nerve regeneration after PNI unclear. To explore the underlying connections between pain and regeneration after PNI and provide potential molecular targets, we performed single-cell RNA sequencing and functional verification in an established rat model, allowing simultaneous study of the neuropathic pain and axonal regeneration after PNI. First, a novel rat model named spared nerve crush (SNC) was created. In this model, two branches of the sciatic nerve were crushed, but the epineurium remained unsevered. This model successfully recapitulated both neuropathic pain and axonal regeneration after PNI, allowing for the study of the intrinsic link between these two crucial biological processes. Dorsal root ganglions (DRGs) from SNC and naïve rats at various time points after SNC were collected for single-cell RNA sequencing (scRNA-seq). After matching all scRNA-seq data to the 7 known DRG types, we discovered that the PEP1 and PEP3 DRG neuron subtypes increased in crushed and uncrushed DRG separately after SNC. Using experimental design scRNA-seq processing (EDSSP), we identified Adcyap1 as a potential gene contributing to both pain and nerve regeneration. Indeed, repeated intrathecal administration of PACAP38 mitigated pain and facilitated axonal regeneration, while Adcyap1 siRNA or PACAP6-38, an antagonist of PAC1R (a receptor of PACAP38) led to both mechanical hyperalgesia and delayed DRG axon regeneration in SNC rats. Moreover, these effects can be reversed by repeated intrathecal administration of PACAP38 in the acute phase but not the late phase after PNI, resulting in alleviated pain and promoted axonal regeneration. Our study reveals that Adcyap1 is an intrinsic protective factor linking neuropathic pain and axonal regeneration following PNI. This finding provides new potential targets and strategies for early therapeutic intervention of PNI.

NeuroHeal Treatment Alleviates Neuropathic Pain and Enhances Sensory Axon Regeneration

Delayed Inhibition of ERK and P38 Attenuates Neuropathic Pain Without Affecting Motor Function Recovery after Peripheral Nerve Injury.

Boosted Regeneration and Reduced Denervated Muscle Atrophy by NeuroHeal in a Pre-clinical Model of Lumbar Root Avulsion with Delayed Reimplantation

Enhancement of nerve regeneration with nimodipine treatment after sciatic nerve injury

Reversal of Neuropathic Pain is Associated with Corticostriatal Functional Reorganization after Nerve Repair in the Spared Nerve Injury Model

Unveiling Adcyap1 As a Protective Factor Linking Pain and Nerve Regeneration Through Single-Cell RNA Sequencing of Rat Dorsal Root Ganglion Neurons.

Neurotropin® accelerates peripheral nerve regeneration in a rat sciatic nerve crush injury model

Dual Role of Ibuprofen and Indomethacin in Promoting Peripheral Nerve Regeneration In Vitro

Effect of Nimodipine and Botulinum Toxin A on Peripheral Nerve Regeneration in Rats: A Pilot Study

Improving peripheral nerve regeneration: from molecular mechanisms to potential therapeutic targets

Effects of Regenerative Peripheral Nerve Interface on Dorsal Root Ganglia Neurons Following Peripheral Axotomy

Neural Mobilization Reverses Behavioral and Cellular Changes That Characterize Neuropathic Pain in Rats

Injectable, Antioxidative, And Neurotrophic Factor-Deliverable Hydrogel For Peripheral Nerve Regeneration And Neuropathic Pain Relief

Prevention and reversal of neuropathic pain by near-infrared photobiomodulation therapy in male and female rats

Anti-Allodynic Effects of Polydeoxyribonucleotide in an Animal Model of Neuropathic Pain and Complex Regional Pain Syndrome

Regenerative Peripheral Nerve Interface Surgery for the Management of Chronic Posttraumatic Neuropathic Pain

Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain

Autophagy-targeting modulation to promote peripheral nerve regeneration

BDNF Promotes the Axonal Regrowth after Sciatic Nerve Crush Through Intrinsic Neuronal Capability Upregulation and Distal Portion Protection.

Regenerative peripheral neuropathic pain: novel pathological pain, new therapeutic dimension

Single Injection of a Novel Nerve Growth Factor Coacervate Improves Structural and Functional Regeneration after Sciatic Nerve Injury in Adult Rats.